Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Aug 03, 2021 1:32pm
118 Views
Post# 33642819

RE:RE:RE:RE:RE:RE:RE:RE:Advisor Group Holdings

RE:RE:RE:RE:RE:RE:RE:RE:Advisor Group Holdings I monitor that in the Weekly Report Card and I have not seen much of anything on that front. LSA apparently reaches out to some high net worth retail investors but, other than that, I am not aware of any effort to engage with retail investors. Given the low market cap of THTX, it is not r eally eliglble for many institutional investors to invest in. And given the burgeoning retail investor class that could, it really does not make much sense for the company to not engage with them. But they have not shown any interest in doing so and that is very unforunate since the share price could easily be much higher with a legitimate outreach to those investors as Scarlett has pointed out as much as any human could possibly do. But, if TH is not interested, then we are going to be stuck with a sub-optimal share price until the market cap rises to the level where institutions can become a factor. 

Lee430 wrote: Has anyone seen evidence that Thera is making a reasonable effort to engage the retail investors after Wino’s meeting representing us?

  


Wino115 wrote: There's so many reasons investors have to buy and sell that there is also something on offer either higher or lower.  But we do know from our Board discussion that PL said a large Quebec institution felt the new "brand" introduced far too much risk for them. They didn't buy in the last offering, so maybe they're also selling as it rises.  Rather dumb since they can walk down the street and get an incredibly detailed review of the science and assess the pipeline prospects.  Institutional inertia is a huge problem in the investment business.   There's also always index and tracker rebalancing and they are in a few of those indexes now.   It won't be major, but then again the volumes aren't major either. 


scarlet1967 wrote: Because of unmotivated investors, they try to bring individual investors onboard with all these behind closed doors talks. How about thousands of retail investors which need to be motivated?A multi marketing strategies will have multiple shots on their targets the sooner they start it the better imo.

Bucknelly21 wrote: Can someone answer this for me? Why does it always seem that whenever there is buying there always seems to be an equal amount of selling? I really have a hard time figuring out who keeps selling?

 

 




<< Previous
Bullboard Posts
Next >>